{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:52:45Z","timestamp":1791989565121,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2021YFA1300601"],"award-info":[{"award-number":["2021YFA1300601"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24QA2710000"],"award-info":[{"award-number":["24QA2710000"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82425103"],"award-info":[{"award-number":["82425103"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82341012"],"award-info":[{"award-number":["82341012"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82203495"],"award-info":[{"award-number":["82203495"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82372771"],"award-info":[{"award-number":["82372771"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["81825018"],"award-info":[{"award-number":["81825018"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82130085"],"award-info":[{"award-number":["82130085"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association of the Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ccell.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:54:20Z","timestamp":1745495660000},"page":"1261-1278.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy"],"prefix":"10.1016","volume":"43","author":[{"given":"Jiacheng","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuege","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beitao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannan","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naiheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zige","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huairui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2263-128X","authenticated-orcid":false,"given":"Jun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMe0901737","article-title":"Androgen deprivation in prostate cancer--step by step","volume":"360","author":"Albertsen","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.04.002_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1903835","article-title":"Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer","volume":"381","author":"Davis","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.1168175","article-title":"Development of a second-generation antiandrogen for treatment of advanced prostate cancer","volume":"324","author":"Tran","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.04.002_bib4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc4016","article-title":"Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer","volume":"15","author":"Watson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrclinonc.2014.72","article-title":"Evolution of androgen receptor targeted therapy for advanced prostate cancer","volume":"11","author":"Wong","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ccell.2025.04.002_bib6","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1172\/JCI41824","article-title":"Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant","volume":"120","author":"Sun","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1093\/annonc\/mdv267","article-title":"Treatment of mCRPC in the AR-axis-targeted therapy-resistant state","volume":"26","author":"Chi","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ccell.2025.04.002_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib10","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-16-1174","article-title":"Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer","volume":"7","author":"Zou","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.04.002_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.04.002_bib13","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1038\/s41591-018-0241-1","article-title":"ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis","volume":"24","author":"Rotinen","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.04.002_bib14","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.04.002_bib15","article-title":"Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study","volume":"4","author":"Cackowski","year":"2020","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.ccell.2025.04.002_bib16","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1001\/jamaoncol.2017.0751","article-title":"Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy","volume":"3","author":"Zhao","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ccell.2025.04.002_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/iju5.12363","article-title":"Androgen receptor-neuroendocrine double-negative tumor with squamous differentiation arising from treatment-refractory metastatic castration-resistant prostate cancer","volume":"4","author":"Sawazaki","year":"2021","journal-title":"IJU Case Rep."},{"key":"10.1016\/j.ccell.2025.04.002_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.04.002_bib19","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s43018-022-00380-3","article-title":"Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer","volume":"3","author":"Cheng","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib20","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1002\/jcb.26086","article-title":"Combination of Carmustine and Selenite Inhibits EGFR Mediated Growth Signaling in Androgen-Independent Prostate Cancer Cells","volume":"118","author":"Thamilselvan","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ccell.2025.04.002_bib21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/sj.bjc.6605376","article-title":"Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth","volume":"101","author":"Traish","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccell.2019.06.009","article-title":"The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression","volume":"36","author":"Su","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.04.002_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ccell.2024.01.012","article-title":"Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer","volume":"42","author":"Tong","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.tcb.2022.08.003","article-title":"\u0394Np63\u03b1 in cancer: importance and therapeutic opportunities","volume":"33","author":"Fisher","year":"2023","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ccell.2025.04.002_bib26","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/s41388-023-02859-4","article-title":"p63: a crucial player in epithelial stemness regulation","volume":"42","author":"Li","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2025.04.002_bib27","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015248","article-title":"p53\/p63\/p73 in the epidermis in health and disease","volume":"4","author":"Botchkarev","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ccell.2025.04.002_bib28","doi-asserted-by":"crossref","first-page":"17969","DOI":"10.1073\/pnas.1309362110","article-title":"ASPP2 suppresses squamous cell carcinoma via RelA\/p65-mediated repression of p63","volume":"110","author":"Tordella","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.04.002_bib29","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1158\/0008-5472.CAN-17-0449","article-title":"YAP Suppresses Lung Squamous Cell Carcinoma Progression via Deregulation of the DNp63-GPX2 Axis and ROS Accumulation","volume":"77","author":"Huang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2025.04.002_bib30","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.04.002_bib31","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.04.002_bib32","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.1073\/pnas.1902651116","article-title":"Genomic correlates of clinical outcome in advanced prostate cancer","volume":"116","author":"Abida","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.04.002_bib33","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/s43018-022-00361-6","article-title":"KMT2C deficiency promotes small cell lung cancer metastasis through DNMT3A-mediated epigenetic reprogramming","volume":"3","author":"Na","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41556-022-01045-0","article-title":"MLL3 loss drives metastasis by promoting a hybrid epithelial-mesenchymal transition state","volume":"25","author":"Cui","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ccell.2025.04.002_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-023-01356-4","article-title":"MLL3\/MLL4 methyltransferase activities control early embryonic development and embryonic stem cell differentiation in a lineage-selective manner","volume":"55","author":"Xie","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.04.002_bib36","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ccr.2014.03.016","article-title":"MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia","volume":"25","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-022-01542-8","article-title":"KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis","volume":"21","author":"Limberger","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib38","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The Molecular Taxonomy of Primary Prostate Cancer","volume":"163","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib39","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41391-022-00618-2","article-title":"Genetic profiling of hormone-sensitive and castration-resistant prostate cancers and identification of genetic mutations prone to castration-resistant prostate cancer","volume":"26","author":"Wang","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ccell.2025.04.002_bib41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrurol.2018.9","article-title":"Clinical implications of PTEN loss in prostate cancer","volume":"15","author":"Jamaspishvili","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ccell.2025.04.002_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","article-title":"Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer","volume":"4","author":"Wang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib43","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","article-title":"Identification of multipotent luminal progenitor cells in human prostate organoid cultures","volume":"159","author":"Karthaus","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nm.4053","article-title":"Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer","volume":"22","author":"Kumar","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.ccell.2025.04.002_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2019.105506","article-title":"The role of adrenal derived androgens in castration resistant prostate cancer","volume":"197","author":"Barnard","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ccell.2025.04.002_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/iju.15424","article-title":"Exploring androgen receptor signaling pathway in prostate cancer: A path to new discoveries","volume":"31","author":"Obinata","year":"2024","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ccell.2025.04.002_bib47","article-title":"A Tmprss2-CreERT2 Knock-In Mouse Model for Cancer Genetic Studies on Prostate and Colon","volume":"11","author":"Gao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ccell.2025.04.002_bib48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccr.2012.01.005","article-title":"Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation","volume":"21","author":"Choi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0303-7207(96)03800-2","article-title":"Functional analysis of the human androgen receptor promoter","volume":"119","author":"Takane","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ccell.2025.04.002_bib50","doi-asserted-by":"crossref","first-page":"9296","DOI":"10.1016\/S0021-9258(18)98349-3","article-title":"Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1","volume":"268","author":"Faber","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccell.2025.04.002_bib51","doi-asserted-by":"crossref","first-page":"13776","DOI":"10.1016\/S0021-9258(18)77416-4","article-title":"Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines","volume":"265","author":"Tilley","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ccell.2025.04.002_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/carcin\/bgi021","article-title":"Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells","volume":"26","author":"Yuan","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ccell.2025.04.002_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/mend.11.1.9868","article-title":"Functional role of a conformationally flexible homopurine\/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein","volume":"11","author":"Chen","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ccell.2025.04.002_bib54","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2353\/ajpath.2009.080727","article-title":"NF-kappaB regulates androgen receptor expression and prostate cancer growth","volume":"175","author":"Zhang","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2025.04.002_bib55","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1038\/onc.2015.496","article-title":"FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression","volume":"35","author":"Zhao","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2025.04.002_bib56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","article-title":"Organoid cultures derived from patients with advanced prostate cancer","volume":"159","author":"Gao","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib57","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.04.002_bib58","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib59","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1093\/nar\/gkx234","article-title":"MLL3\/MLL4 are required for CBP\/p300 binding on enhancers and super-enhancer formation in brown adipogenesis","volume":"45","author":"Lai","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2025.04.002_bib60","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1128\/MCB.01181-13","article-title":"The MLL3\/MLL4 branches of the COMPASS family function as major histone H3K4 monomethylases at enhancers","volume":"33","author":"Hu","year":"2013","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.04.002_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.1630","article-title":"GREAT improves functional interpretation of cis-regulatory regions","volume":"28","author":"McLean","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ccell.2025.04.002_bib62","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41588-024-01669-y","article-title":"Functional dissection of human cardiac enhancers and noncoding de novo variants in congenital heart disease","volume":"56","author":"Xiao","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.04.002_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ng.1006","article-title":"Large-scale discovery of enhancers from human heart tissue","volume":"44","author":"May","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.04.002_bib64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41586-019-1182-7","article-title":"Transcription factors and 3D genome conformation in cell-fate decisions","volume":"569","author":"Stadhouders","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2025.04.002_bib65","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ccell.2025.04.002_bib66","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1101\/gad.10.22.2903","article-title":"SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein","volume":"10","author":"Oliner","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2025.04.002_bib67","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/ERC-15-0556","article-title":"Androgen control of lipid metabolism in prostate cancer: novel insights and future applications","volume":"23","author":"Butler","year":"2016","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib68","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41588-017-0026-3","article-title":"Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.04.002_bib69","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41588-017-0027-2","article-title":"An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.04.002_bib70","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41588-022-01045-8","article-title":"HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer","volume":"54","author":"Lu","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2025.04.002_bib71","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrc3483","article-title":"Cancer metabolism: fatty acid oxidation in the limelight","volume":"13","author":"Carracedo","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccell.2025.04.002_bib72","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1158\/1078-0432.CCR-22-2807","article-title":"Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma","volume":"29","author":"Kelly","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ccell.2025.04.002_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100797","article-title":"First-in-human study of the safety, pharmacokinetics, and pharmacodynamics of first-in-class fatty acid synthase inhibitor TVB-2640 alone and with a taxane in advanced tumors","volume":"34","author":"Falchook","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ccell.2025.04.002_bib74","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ccell.2025.04.002_bib75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physrev.00032.2014","article-title":"The physiology of protein S-acylation","volume":"95","author":"Chamberlain","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ccell.2025.04.002_bib76","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood-2009-03-213876","article-title":"Palmitoylation of oncogenic NRAS is essential for leukemogenesis","volume":"115","author":"Cuiffo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ccell.2025.04.002_bib77","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41589-019-0344-0","article-title":"Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation","volume":"15","author":"Kim","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ccell.2025.04.002_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114516","article-title":"Fatty acid synthesis promotes inflammasome activation through NLRP3 palmitoylation","volume":"43","author":"Leishman","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.04.002_bib79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.12688\/f1000research.6464.1","article-title":"SwissPalm: Protein Palmitoylation database","volume":"4","author":"Blanc","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.ccell.2025.04.002_bib80","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","article-title":"Acquired Resistance to KRAS(G12C) Inhibition in Cancer","volume":"384","author":"Awad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccell.2025.04.002_bib81","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ccell.2022.11.015","article-title":"KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition","volume":"41","author":"Pan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2025.04.002_bib82","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/onc.2017.385","article-title":"Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer","volume":"37","author":"Han","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2025.04.002_bib83","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/pros.10283","article-title":"Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens","volume":"57","author":"Jin","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.ccell.2025.04.002_bib84","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78217","article-title":"Contribution of Trp63(CreERT2)-labeled cells to alveolar regeneration is independent of tuft cells","volume":"11","author":"Huang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ccell.2025.04.002_bib85","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/2159-8290.CD-23-0754","article-title":"Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation","volume":"14","author":"Franceschini","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2025.04.002_bib86","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1194\/jlr.D011106","article-title":"Site-specific analysis of protein S-acylation by resin-assisted capture","volume":"52","author":"Forrester","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ccell.2025.04.002_bib87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.celrep.2018.12.022","article-title":"DHHC4 and DHHC5 Facilitate Fatty Acid Uptake by Palmitoylating and Targeting CD36 to the Plasma Membrane","volume":"26","author":"Wang","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2025.04.002_bib88","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nprot.2016.006","article-title":"Organoid culture systems for prostate epithelial and cancer tissue","volume":"11","author":"Drost","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2025.04.002_bib89","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nprot.2010.11","article-title":"Isolation, cultivation and characterization of adult murine prostate stem cells","volume":"5","author":"Lukacs","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2025.04.002_bib90","doi-asserted-by":"crossref","first-page":"11896","DOI":"10.1073\/pnas.1734139100","article-title":"In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme","volume":"100","author":"Xin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2025.04.002_bib91","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0002-9440(10)64228-9","article-title":"Prostatic intraepithelial neoplasia in genetically engineered mice","volume":"161","author":"Park","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2025.04.002_bib92","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.gie.2021.04.015","article-title":"Keratin pearls in magnifying endoscopy of superficial esophageal squamous cell carcinoma","volume":"94","author":"Baba","year":"2021","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.ccell.2025.04.002_bib93","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.1067799","article-title":"Capturing chromosome conformation","volume":"295","author":"Dekker","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ccell.2025.04.002_bib94","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ccell.2020.05.022","article-title":"SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling Pathways","volume":"38","author":"Yuan","year":"2020","journal-title":"Cancer Cell"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610825001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:07:27Z","timestamp":1762549647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610825001394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":94,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1535610825001394"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2025.04.002","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KMT2C deficiency drives transdifferentiation of double-negative prostate cancer and confer resistance to AR-targeted therapy","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}